Matinas BioPharma Holdings, Inc.

MTNB · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$24-$23-$21-$23
Dep. & Amort.$1$1$1$1
Deferred Tax-$0$0$0$0
Stock-Based Comp.$3$5$0$4
Change in WC-$0$2-$5$2
Other Non-Cash$4$0$6$1
Operating Cash Flow-$16-$15-$19-$15
Investing Activities
PP&E Inv.$0-$0-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$8$0-$9-$23
Inv. Sales/Matur.$18$13$15$40
Other Inv. Act.$0$0$0$0
Investing Cash Flow$9$13$5$17
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$9$0$0$6
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$1
Financing Cash Flow$9-$0$0$7
Forex Effect$0$0$0$0
Net Chg. in Cash$2-$2-$14$9
Supplemental Information
Beg. Cash$5$7$21$13
End Cash$8$5$7$21
Free Cash Flow-$16-$15-$20-$15
Matinas BioPharma Holdings, Inc. (MTNB) Financial Statements & Key Stats | AlphaPilot